Albert Benjamin 4
4 · Health Catalyst, Inc. · Filed Feb 27, 2026
Research Summary
AI-generated summary of this filing
Health Catalyst (HCAT) CEO Albert Benjamin Receives RSU Award
What Happened
Albert Benjamin, CEO and director of Health Catalyst (HCAT), received equity awards on Feb 25, 2026: 930,000 restricted stock units (RSUs) and 38,833 performance-based restricted stock units (PRSUs), for a total of 968,833 contingent units (reported at $0.00 per unit as awards). On Feb 26, 2026 he had 13,304 shares sold at $1.75 per share (total proceeds $23,253) to satisfy tax withholding associated with vesting.
Key Details
- Transactions: 2/25/2026 — Award/Grant (A) of 930,000 RSUs and 38,833 PRSUs (price reported $0.00); 2/26/2026 — Sale/Disposition (F) of 13,304 shares at $1.75 each, proceeds $23,253.
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Vesting/conditions: The RSUs vest 16.67% on March 1, 2026, then the remaining 83.33% in 10 equal quarterly installments (see footnote). The 38,833 PRSUs are performance-based and contingent on 2025 performance metrics.
- Tax withholding: The 13,304-share sale was a mandated "sell to cover" to satisfy tax withholding under the company's equity plan (non-discretionary), not a voluntary open-market sale by the CEO.
- Filing: Form filed Feb 27, 2026 and discloses transactions on Feb 25–26, 2026 (reported filing date available).
Context
- RSUs/PRSUs are awards that convert to shares if vesting and/or performance conditions are met; they are not cash purchases and do not imply a purchase-based bullish signal.
- The small sell (13,304 shares) was to cover taxes only, per company policy; such sell-to-cover transactions are routine following vesting.
- For retail investors, awards increase potential future share issuance; purchases by insiders are generally more indicative of conviction than awards or mandatory tax sales.
Insider Transaction Report
Form 4
Albert Benjamin
DirectorCEO
Transactions
- Award
Common Stock
[F1]2026-02-25+930,000→ 1,507,870 total - Award
Common Stock
[F2]2026-02-25+38,833→ 1,546,703 total - Tax Payment
Common Stock
[F3]2026-02-26$1.75/sh−13,304$23,253→ 1,533,399 total
Footnotes (3)
- [F1]Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 16.67% of the RSUs will vest on March 1st, 2026, and, thereafter, the remaining 83.33% of the RSUs will vest in 10 equal quarterly installments.
- [F2]Represents an award of 38,833 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Each PRSU represents a contingent right to receive one share of the Issuer's common stock.
- [F3]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Signature
/s/ Benjamin Landry, as Attorney-in-Fact|2026-02-27